Q3 2024 Holdings
Filed 2024-11-14 | 196 holdings | $6.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Incyte Corp(INCY) | COM | 45337C102 | $142.2M | 2,150,551 | 2.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $166.0M | 3,735,915 | 2.7% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $181.9M | 2,485,627 | 2.9% |
| Stryker Corporation(SYK) | COM | 863667101 | $190.2M | 526,607 | 3.1% |
| Abbott Labs(ABT) | COM | 002824100 | $198.8M | 1,743,938 | 3.2% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $205.5M | 2,452,797 | 3.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $214.7M | 1,863,800 | 3.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $220.9M | 4,871,360 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $222.5M | 809,095 | 3.6% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $244.1M | 496,775 | 4.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $265.7M | 571,406 | 4.3% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $315.4M | 7,874,400 | 5.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $343.0M | 632,829 | 5.6% |